<?xml version="1.0"  ?><!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd"><pmc-articleset><article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" article-type="research-article" xml:lang="en" dtd-version="1.4"><front><journal-meta><journal-id journal-id-type="nlm-ta">Cytometry A</journal-id><journal-id journal-id-type="iso-abbrev">Cytometry A</journal-id><journal-id journal-id-type="pmc-domain-id">379</journal-id><journal-id journal-id-type="pmc-domain">blackwellopen</journal-id><journal-id journal-id-type="publisher-id">CYTO</journal-id><journal-title-group><journal-title>Cytometry</journal-title></journal-title-group><issn pub-type="ppub">1552-4922</issn><issn pub-type="epub">1552-4930</issn><custom-meta-group><custom-meta><meta-name>pmc-is-collection-domain</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-collection-title</meta-name><meta-value>Wiley Open Access Collection</meta-value></custom-meta></custom-meta-group></journal-meta><article-meta><article-id pub-id-type="pmcid">PMC7702032</article-id><article-id pub-id-type="pmcid-ver">PMC7702032.1</article-id><article-id pub-id-type="pmcaid">7702032</article-id><article-id pub-id-type="pmcaiid">7702032</article-id><article-id pub-id-type="pmid">32978859</article-id><article-id pub-id-type="doi">10.1002/cyto.a.24230</article-id><article-id pub-id-type="publisher-id">CYTOA24230</article-id><article-version article-version-type="pmc-version">1</article-version><article-categories><subj-group subj-group-type="overline"><subject>Omip</subject></subj-group><subj-group subj-group-type="heading"><subject>Celebrating 10 Years OMIP</subject><subj-group subj-group-type="heading"><subject>OMIPs</subject></subj-group></subj-group></article-categories><title-group><article-title>
<styled-content style="fixed-case" toggle="no">OMIP</styled-content>&#8208;070: <styled-content style="fixed-case" toggle="no">NKp46</styled-content>&#8208;Based 27&#8208;Color Phenotyping to Define Natural Killer Cells Isolated From Human Tumor Tissues</article-title><alt-title alt-title-type="right-running-head"><styled-content style="fixed-case" toggle="no">OMIP</styled-content>&#8208;070: <styled-content style="fixed-case" toggle="no">NKp46</styled-content>&#8208;Based 27&#8208;Color Phenotyping to Define Natural Killer Cells Isolated From Human Tumor Tissues</alt-title></title-group><contrib-group><contrib id="cytoa24230-cr-0001" contrib-type="author"><name name-style="western"><surname>Frutoso</surname><given-names initials="M">Marie</given-names></name><contrib-id contrib-id-type="orcid" authenticated="false">https://orcid.org/0000-0002-7848-1049</contrib-id><xref ref-type="aff" rid="cytoa24230-aff-0001">
<sup>1</sup>
</xref></contrib><contrib id="cytoa24230-cr-0002" contrib-type="author"><name name-style="western"><surname>Mair</surname><given-names initials="F">Florian</given-names></name><contrib-id contrib-id-type="orcid" authenticated="false">https://orcid.org/0000-0001-6732-5449</contrib-id><xref ref-type="aff" rid="cytoa24230-aff-0001">
<sup>1</sup>
</xref></contrib><contrib id="cytoa24230-cr-0003" contrib-type="author" corresp="yes"><name name-style="western"><surname>Prlic</surname><given-names initials="M">Martin</given-names></name><contrib-id contrib-id-type="orcid" authenticated="false">https://orcid.org/0000-0002-0685-9321</contrib-id><xref ref-type="aff" rid="cytoa24230-aff-0001">
<sup>1</sup>
</xref><address><email>mprlic@fredhutch.org</email></address></contrib></contrib-group><aff id="cytoa24230-aff-0001">
<label><sup>1</sup></label>
<named-content content-type="organisation-division">Vaccine and Infectious Disease Division</named-content>
<institution>Fred Hutchinson Cancer Research Center</institution>
<city>Seattle</city>
<named-content content-type="country-part">Washington</named-content>
<postal-code>98109</postal-code>
<country country="US">USA</country>
</aff><author-notes><corresp id="correspondenceTo"><label>*</label>
Correspondence to: Martin Prlic, Vaccine and Infectious Disease Division, 7 Fred Hutchinson Cancer Research Center, 8 Seattle WA 98109, USA.<break/>
Email: <email>mprlic@fredhutch.org</email>.<break/></corresp></author-notes><pub-date pub-type="epub"><day>08</day><month>10</month><year>2020</year></pub-date><pub-date pub-type="ppub"><month>10</month><year>2020</year></pub-date><volume>97</volume><issue>10</issue><issue-id pub-id-type="pmc-issue-id">369756</issue-id><issue-id pub-id-type="doi">10.1002/cyto.a.v97.10</issue-id><fpage>1052</fpage><lpage>1056</lpage><history><date date-type="received"><day>09</day><month>6</month><year>2020</year></date><date date-type="rev-recd"><day>05</day><month>8</month><year>2020</year></date><date date-type="accepted"><day>14</day><month>9</month><year>2020</year></date></history><pub-history><event event-type="pmc-release"><date><day>30</day><month>11</month><year>2020</year></date></event><event event-type="pmc-live"><date><day>14</day><month>12</month><year>2020</year></date></event><event event-type="pmc-last-change"><date iso-8601-date="2020-12-15 00:16:15.420"><day>15</day><month>12</month><year>2020</year></date></event></pub-history><permissions><copyright-statement content-type="article-copyright">&#169; 2020 The Authors. <italic toggle="yes">Cytometry Part A</italic> published by Wiley Periodicals LLC on behalf of International Society for Advancement of Cytometry.</copyright-statement><license license-type="creativeCommonsBy-nc"><ali:license_ref specific-use="textmining" content-type="ccbynclicense">https://creativecommons.org/licenses/by-nc/4.0/</ali:license_ref><license-p>This is an open access article under the terms of the <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by-nc/4.0/">http://creativecommons.org/licenses/by-nc/4.0/</ext-link> License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited and is not used for commercial purposes.</license-p></license></permissions><self-uri xmlns:xlink="http://www.w3.org/1999/xlink" content-type="pmc-pdf" xlink:href="CYTO-97-1052.pdf"/><self-uri xmlns:xlink="http://www.w3.org/1999/xlink" content-type="pdf" xlink:href="file:CYTO-97-1052.pdf"/><abstract><title>Purpose and appropriate samples</title><p>This 27&#8208;color panel has been validated and optimized to comprehensively profile natural killer (NK) cells isolated from human tumors using a collagenase Type II&#8208;based digestion protocol. We confirmed that detection of protein expression by antibodies used in our final panel was not affected during tissue digestion. During this evaluation process, we found that detection of CD56, a biomarker typically used to identify NK cells, was affected substantially by collagenase&#8208;based digestion. Thus, our panel is centered around expression of NKp46, which is sufficient to identify NK cells and not affected by the tissue collagenase digestion step. Our panel further includes biomarkers used to extrapolate NK&#8208;cell maturation, differentiation, migration, homing potential, and functional state. Our panel is intended to provide in&#8208;depth characterization of human NK cells isolated from tissues, which we specifically tested using oral squamous cell carcinomas tissues, but it is compatible with other tissues that can be dissociated with a collagenase Type II&#8208;based protocol. &#169; 2020 The Authors. <italic toggle="yes">Cytometry Part A</italic> published by Wiley Periodicals LLC on behalf of International Society for Advancement of Cytometry.</p></abstract><abstract abstract-type="graphical"><p>
<boxed-text position="anchor" content-type="graphic" id="cytoa24230-blkfxd-0001" orientation="portrait"><graphic xmlns:xlink="http://www.w3.org/1999/xlink" position="anchor" id="nlm-graphic-1" orientation="portrait" xlink:href="CYTO-97-1052-g002.jpg"/></boxed-text>This OMIP describes a 27&#8208;color flow cytometry panel suited to characterize NK cells isolated from human tissues. This panel was optimized for compatibility with collagenase type II&#8208;based digestion.</p></abstract><kwd-group kwd-group-type="author-generated"><kwd id="cytoa24230-kwd-0001">high&#8208;dimensional cytometry</kwd><kwd id="cytoa24230-kwd-0002">natural killer cells</kwd><kwd id="cytoa24230-kwd-0003">human tumor</kwd><kwd id="cytoa24230-kwd-0004">immunophenotyping</kwd><kwd id="cytoa24230-kwd-0005">human tissue</kwd><kwd id="cytoa24230-kwd-0006">human PBMCs</kwd></kwd-group><funding-group><award-group id="funding-0001"><funding-source><institution-wrap><institution>National Institute of Allergy and Infectious Diseases </institution><institution-id institution-id-type="open-funder-registry">10.13039/100000060</institution-id></institution-wrap></funding-source><award-id>R01AI123323 (to M.P.)</award-id></award-group><award-group id="funding-0002"><funding-source><institution-wrap><institution>The American Association of Immunologists </institution><institution-id institution-id-type="open-funder-registry">10.13039/100002570</institution-id></institution-wrap></funding-source></award-group></funding-group><counts><fig-count count="1"/><table-count count="2"/><page-count count="5"/><word-count count="4613"/></counts><custom-meta-group><custom-meta><meta-name>pmc-status-qastatus</meta-name><meta-value>0</meta-value></custom-meta><custom-meta><meta-name>pmc-status-live</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-status-embargo</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-status-released</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-open-access</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-olf</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-manuscript</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-legally-suppressed</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-has-pdf</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-has-supplement</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-pdf-only</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-suppress-copyright</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-is-real-version</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-is-scanned-article</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-preprint</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-in-epmc</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-license-ref</meta-name><meta-value>CC BY-NC</meta-value></custom-meta><custom-meta><meta-name>source-schema-version-number</meta-name><meta-value>2.0</meta-value></custom-meta><custom-meta><meta-name>cover-date</meta-name><meta-value>October 2020</meta-value></custom-meta><custom-meta><meta-name>details-of-publishers-convertor</meta-name><meta-value>Converter:WILEY_ML3GV2_TO_JATSPMC version:5.9.4 mode:remove_FC converted:30.11.2020</meta-value></custom-meta></custom-meta-group></article-meta></front><body id="cytoa24230-body-0001"><sec id="cytoa24230-sec-0001"><title>Background</title><p>Natural killer (NK) cells were first identified in the 1970s for their spontaneous cytotoxicity against target cells (<xref rid="cytoa24230-bib-0001" ref-type="ref">1</xref>, <xref rid="cytoa24230-bib-0002" ref-type="ref">2</xref>). Based on this ability to eliminate tumor cells without the need of prior immunization, it has been proposed that NK cells possess an ongoing preventive role to eliminate malignantly transformed cells and contribute to the control of hematologic malignancies or tumor metastasis (<xref rid="cytoa24230-bib-0003" ref-type="ref">3</xref>, <xref rid="cytoa24230-bib-0004" ref-type="ref">4</xref>). In addition to exerting direct cytotoxicity, NK cells are also able to produce cytokines and chemokines that modulate the local microenvironment and recruit additional immune cells (<xref rid="cytoa24230-bib-0005" ref-type="ref">5</xref>, <xref rid="cytoa24230-bib-0006" ref-type="ref">6</xref>, <xref rid="cytoa24230-bib-0007" ref-type="ref">7</xref>, <xref rid="cytoa24230-bib-0008" ref-type="ref">8</xref>). Together, these data suggest that NK cells could make significant contributions to antitumor immune responses in solid tumors (<xref rid="cytoa24230-bib-0009" ref-type="ref">9</xref>). However, a more in&#8208;depth analysis of intra&#8208;tumoral NK cells is needed to further decipher how NK cells affect tumor growth. Of note, multiple studies have shown that the tumor progression and outcomes in humans correlate with the presence of NK cells at the tumor site (<xref rid="cytoa24230-bib-0010" ref-type="ref">10</xref>, <xref rid="cytoa24230-bib-0011" ref-type="ref">11</xref>, <xref rid="cytoa24230-bib-0012" ref-type="ref">12</xref>, <xref rid="cytoa24230-bib-0013" ref-type="ref">13</xref>, <xref rid="cytoa24230-bib-0014" ref-type="ref">14</xref>) highlighting that these cells are of interest for the development of immunotherapeutic approaches in solid tumors (<xref rid="cytoa24230-bib-0015" ref-type="ref">15</xref>, <xref rid="cytoa24230-bib-0016" ref-type="ref">16</xref>, <xref rid="cytoa24230-bib-0017" ref-type="ref">17</xref>, <xref rid="cytoa24230-bib-0018" ref-type="ref">18</xref>).</p><p>One roadblock to study human NK cells isolated from tumors is the limited amount of tissue that is typically available from biopsies or tumor resections. It is thus of utmost importance to extract as much information as possible from the tumor sample on a single&#8208;cell level while minimizing further sample loss (Table <xref rid="cytoa24230-tbl-0001" ref-type="table">1</xref>).</p><table-wrap id="cytoa24230-tbl-0001" xml:lang="en" content-type="Table" orientation="portrait" position="float"><label>Table 1</label><caption><p>Summary table for application of this OMIP</p></caption><table frame="hsides" rules="groups"><col align="left" span="1"/><col align="left" span="1"/><thead valign="bottom"><tr style="border-bottom:solid 1px #000000"><th align="left" valign="bottom" rowspan="1" colspan="1">Purpose</th><th align="center" valign="bottom" rowspan="1" colspan="1">Immunophenotyping of human NK cells in tumor tissues</th></tr></thead><tbody valign="top"><tr><td align="left" valign="top" rowspan="1" colspan="1">Species</td><td align="left" valign="top" rowspan="1" colspan="1">Human</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Cell types</td><td align="left" valign="top" rowspan="1" colspan="1">Tumor tissues and peripheral blood. Oral squamous cell carcinoma tissues with donor&#8208;matched blood were used to profile NK cells with this 27&#8208;color panel</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Cross&#8208;references</td><td align="left" valign="top" rowspan="1" colspan="1">OMIP&#8208;007, OMIP&#8208;027, OMIP&#8208;029, OMIP&#8208;039, OMIP&#8208;056, OMIP&#8208;058, OMIP&#8208;064</td></tr></tbody></table></table-wrap><p>The first critical step to profile infiltrating NK cells is to obtain a single&#8208;cell suspension yielding a high viability with minimal cell debris and preserved ability to detect critical cell surface antigens. Here, we used a well&#8208;established digestion method combining collagenase Type II and DNase. This collagenase Type II&#8208;based protocol has been used for nearly 20&#8201;years and yields an excellent percentage of viable mucosal mononuclear cells when processing human mucosal tissues (<xref rid="cytoa24230-bib-0019" ref-type="ref">19</xref>, <xref rid="cytoa24230-bib-0020" ref-type="ref">20</xref>, <xref rid="cytoa24230-bib-0021" ref-type="ref">21</xref>).</p><p>The second critical step is to extract as much information as possible from this cell suspension. To that end, high parameter flow cytometry is particularly well suited. Indeed, while cell loss can occur during staining and washing procedures, it is minimal during acquisition, with a current cell transmission efficiency greater than 95% for a standard fluorescence&#8208;based flow cytometer (<xref rid="cytoa24230-bib-0022" ref-type="ref">22</xref>).</p><p>Here, we report the development and validation of a 27&#8208;parameter flow cytometry panel suitable to define the phenotype and activation status of NK cells isolated from human tumor tissues. We use a type II collagenase&#8208;based isolation protocol, which ensures that the panel described here is useful and applicable for a range of human mucosal tissues and possibly others (<xref rid="cytoa24230-bib-0020" ref-type="ref">20</xref>, <xref rid="cytoa24230-bib-0023" ref-type="ref">23</xref>, <xref rid="cytoa24230-bib-0024" ref-type="ref">24</xref>). All reagents included in the final panel are listed in Table <xref rid="cytoa24230-tbl-0002" ref-type="table">2</xref>.</p><table-wrap id="cytoa24230-tbl-0002" xml:lang="en" content-type="Table" orientation="portrait" position="float"><label>Table 2</label><caption><p>Reagents used for OMIP&#8208;070</p></caption><table frame="hsides" rules="groups"><col align="left" span="1"/><col align="left" span="1"/><col align="center" span="1"/><col align="left" span="1"/><col align="left" span="1"/><thead valign="bottom"><tr style="border-bottom:solid 1px #000000"><th align="left" valign="bottom" rowspan="1" colspan="1">Specificity</th><th align="center" valign="bottom" rowspan="1" colspan="1">Alternative name</th><th align="center" valign="bottom" rowspan="1" colspan="1">Clone</th><th align="center" valign="bottom" rowspan="1" colspan="1">Fluorochome</th><th align="center" valign="bottom" rowspan="1" colspan="1">Purpose</th></tr></thead><tbody valign="top"><tr><td colspan="5" align="left" valign="top" rowspan="1">
<italic toggle="yes">Lineage</italic>
</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Dead cells</td><td align="left" valign="top" rowspan="1" colspan="1">N.A.</td><td align="center" valign="top" rowspan="1" colspan="1">N.A.</td><td align="left" valign="top" rowspan="1" colspan="1">Blue</td><td align="left" valign="top" rowspan="1" colspan="1">Viability</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">CD45</td><td align="left" valign="top" rowspan="1" colspan="1">Protein tyrosine phosphatase receptor type C</td><td align="center" valign="top" rowspan="1" colspan="1">HI30</td><td align="left" valign="top" rowspan="1" colspan="1">BUV805</td><td align="left" valign="top" rowspan="1" colspan="1">Lymphocytes</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">CD14</td><td align="left" valign="top" rowspan="1" colspan="1">N.A.</td><td align="center" valign="top" rowspan="1" colspan="1">M5E2</td><td align="left" valign="top" rowspan="1" colspan="1">BV570</td><td align="left" valign="top" rowspan="1" colspan="1">Monocytes</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">CD19</td><td align="left" valign="top" rowspan="1" colspan="1">N.A.</td><td align="center" valign="top" rowspan="1" colspan="1">SJ25&#8208;C1</td><td align="left" valign="top" rowspan="1" colspan="1">BUV395</td><td align="left" valign="top" rowspan="1" colspan="1">B cells</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">CD3</td><td align="left" valign="top" rowspan="1" colspan="1">N.A.</td><td align="center" valign="top" rowspan="1" colspan="1">UCHT1</td><td align="left" valign="top" rowspan="1" colspan="1">BUV661</td><td align="left" valign="top" rowspan="1" colspan="1">T cells</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">CD127</td><td align="left" valign="top" rowspan="1" colspan="1">IL&#8208;7R&#945;</td><td align="center" valign="top" rowspan="1" colspan="1">HIL&#8208;7R&#8208;M21</td><td align="left" valign="top" rowspan="1" colspan="1">BV786</td><td align="left" valign="top" rowspan="1" colspan="1">ILC</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">HLA&#8208;DR</td><td align="left" valign="top" rowspan="1" colspan="1">MHC class II molecule</td><td align="center" valign="top" rowspan="1" colspan="1">G46.6</td><td align="left" valign="top" rowspan="1" colspan="1">APC&#8208;H7</td><td align="left" valign="top" rowspan="1" colspan="1">Exclusion / activation marker</td></tr><tr><td colspan="5" align="left" valign="top" rowspan="1">
<italic toggle="yes">NK cell identification</italic>
</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">NKp46</td><td align="left" valign="top" rowspan="1" colspan="1">CD335, NCR1</td><td align="center" valign="top" rowspan="1" colspan="1">9E2</td><td align="left" valign="top" rowspan="1" colspan="1">Biotin</td><td align="left" valign="top" rowspan="1" colspan="1">NK cell marker and activating receptor</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Streptavidin</td><td align="left" valign="top" rowspan="1" colspan="1">N.A.</td><td align="center" valign="top" rowspan="1" colspan="1">N.A.</td><td align="left" valign="top" rowspan="1" colspan="1">BB630</td><td align="left" valign="top" rowspan="1" colspan="1">N.A.</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">CD16</td><td align="left" valign="top" rowspan="1" colspan="1">Fc&#947;RIII</td><td align="center" valign="top" rowspan="1" colspan="1">3G8</td><td align="left" valign="top" rowspan="1" colspan="1">BUV496</td><td align="left" valign="top" rowspan="1" colspan="1">NK cell marker and ADCC</td></tr><tr><td colspan="5" align="left" valign="top" rowspan="1">
<italic toggle="yes">NK cell markers</italic>
</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">NKG2D</td><td align="left" valign="top" rowspan="1" colspan="1">CD314, KLRK1</td><td align="center" valign="top" rowspan="1" colspan="1">1D11</td><td align="left" valign="top" rowspan="1" colspan="1">PE&#8208;Cy7</td><td align="left" valign="top" rowspan="1" colspan="1">Activating receptor</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">CD244</td><td align="left" valign="top" rowspan="1" colspan="1">2B4</td><td align="center" valign="top" rowspan="1" colspan="1">2&#8211;69</td><td align="left" valign="top" rowspan="1" colspan="1">BV421</td><td align="left" valign="top" rowspan="1" colspan="1">Activating receptor</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">CD2</td><td align="left" valign="top" rowspan="1" colspan="1">Cluster of differentiation 2</td><td align="center" valign="top" rowspan="1" colspan="1">RPA&#8208;2.10</td><td align="left" valign="top" rowspan="1" colspan="1">BV605</td><td align="left" valign="top" rowspan="1" colspan="1">Co&#8208;stimulatory receptor</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">NKG2A</td><td align="left" valign="top" rowspan="1" colspan="1">CD159a</td><td align="center" valign="top" rowspan="1" colspan="1">REA110</td><td align="left" valign="top" rowspan="1" colspan="1">PE</td><td align="left" valign="top" rowspan="1" colspan="1">Inhibitory receptor</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">CD161</td><td align="left" valign="top" rowspan="1" colspan="1">NKR&#8208;P1</td><td align="center" valign="top" rowspan="1" colspan="1">DX12</td><td align="left" valign="top" rowspan="1" colspan="1">BB700</td><td align="left" valign="top" rowspan="1" colspan="1">Inhibitory receptor</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">TIGIT</td><td align="left" valign="top" rowspan="1" colspan="1">T&#8208;cell immunoreceptor with Ig and ITIM domains</td><td align="center" valign="top" rowspan="1" colspan="1">741182</td><td align="left" valign="top" rowspan="1" colspan="1">BV711</td><td align="left" valign="top" rowspan="1" colspan="1">Co&#8208;inhibitory receptor</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">CD69</td><td align="left" valign="top" rowspan="1" colspan="1">Cluster of differentiation 69</td><td align="center" valign="top" rowspan="1" colspan="1">FN50</td><td align="left" valign="top" rowspan="1" colspan="1">BV650</td><td align="left" valign="top" rowspan="1" colspan="1">Residency and activation</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">CD39</td><td align="left" valign="top" rowspan="1" colspan="1">Cluster of differentiation 39</td><td align="center" valign="top" rowspan="1" colspan="1">TU66</td><td align="left" valign="top" rowspan="1" colspan="1">PE&#8208;CF594</td><td align="left" valign="top" rowspan="1" colspan="1">Residency and activation</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">CD103</td><td align="left" valign="top" rowspan="1" colspan="1">Integrin alpha E</td><td align="center" valign="top" rowspan="1" colspan="1">Ber&#8208;ACT8</td><td align="left" valign="top" rowspan="1" colspan="1">BV750</td><td align="left" valign="top" rowspan="1" colspan="1">Residency</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">CX3CR1</td><td align="left" valign="top" rowspan="1" colspan="1">Fractalkine receptor</td><td align="center" valign="top" rowspan="1" colspan="1">2A9&#8208;1</td><td align="left" valign="top" rowspan="1" colspan="1">BUV737</td><td align="left" valign="top" rowspan="1" colspan="1">Migration</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">CD57</td><td align="left" valign="top" rowspan="1" colspan="1">HNK&#8208;1, Leu&#8208;7</td><td align="center" valign="top" rowspan="1" colspan="1">NK&#8208;1</td><td align="left" valign="top" rowspan="1" colspan="1">FITC</td><td align="left" valign="top" rowspan="1" colspan="1">Maturation and differentiation</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">CD27</td><td align="left" valign="top" rowspan="1" colspan="1">Tumor necrosis factor receptor superfamily 7</td><td align="center" valign="top" rowspan="1" colspan="1">M&#8208;T271</td><td align="left" valign="top" rowspan="1" colspan="1">BB660</td><td align="left" valign="top" rowspan="1" colspan="1">Maturation</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">CD11b</td><td align="left" valign="top" rowspan="1" colspan="1">Integrin alpha M</td><td align="center" valign="top" rowspan="1" colspan="1">ICRF44</td><td align="left" valign="top" rowspan="1" colspan="1">PE&#8208;Cy5</td><td align="left" valign="top" rowspan="1" colspan="1">Maturation and adhesion</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">CD38</td><td align="left" valign="top" rowspan="1" colspan="1">Cyclic ADP ribose hydrolase</td><td align="center" valign="top" rowspan="1" colspan="1">HIT2</td><td align="left" valign="top" rowspan="1" colspan="1">BB790</td><td align="left" valign="top" rowspan="1" colspan="1">Activation</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Ki67</td><td align="left" valign="top" rowspan="1" colspan="1">N.A.</td><td align="center" valign="top" rowspan="1" colspan="1">Sola15</td><td align="left" valign="top" rowspan="1" colspan="1">eFluor660</td><td align="left" valign="top" rowspan="1" colspan="1">Proliferation</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Granzyme B</td><td align="left" valign="top" rowspan="1" colspan="1">N.A.</td><td align="center" valign="top" rowspan="1" colspan="1">QA16A2</td><td align="left" valign="top" rowspan="1" colspan="1">AF700</td><td align="left" valign="top" rowspan="1" colspan="1">Cytolytic abilities</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">CD25</td><td align="left" valign="top" rowspan="1" colspan="1">IL&#8208;2R&#945;</td><td align="center" valign="top" rowspan="1" colspan="1">2A3</td><td align="left" valign="top" rowspan="1" colspan="1">BUV563</td><td align="left" valign="top" rowspan="1" colspan="1">Activation</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">CD56</td><td align="left" valign="top" rowspan="1" colspan="1">Neural cell adhesion molecule (NCAM)</td><td align="center" valign="top" rowspan="1" colspan="1">CMSSB</td><td align="left" valign="top" rowspan="1" colspan="1">PECy5.5</td><td align="left" valign="top" rowspan="1" colspan="1">Activation marker and NK&#8208;cell marker for peripheral blood</td></tr></tbody></table></table-wrap><p>In order to identify NK cells in tumor tissue, we applied the gating strategy depicted in Figure <xref rid="cytoa24230-fig-0001" ref-type="fig">1A</xref>. This gating strategy was designed to ensure that other immune populations such as B cells, T cells, and monocytes, could also be enumerated. NK cells were gated as live hematopoietic cells (Dead<sup>&#8722;</sup>, CD45<sup>+</sup>), non B cells (CD19<sup>&#8722;</sup>), non&#8208;monocytes (CD14<sup>&#8722;</sup>), non T cells (CD3<sup>&#8722;</sup>), non&#8208;innate lymphoid cells (ILC) (CD127<sup>&#8722;</sup>), and HLA&#8208;DR<sup>&#8722;</sup> cells (Fig. <xref rid="cytoa24230-fig-0001" ref-type="fig">1A</xref>). Of note, HLA&#8208;DR is a common surrogate for immune activation on lymphocytes (<xref rid="cytoa24230-bib-0025" ref-type="ref">25</xref>) that has been reported to be expressed by a fraction of NK cells (<xref rid="cytoa24230-bib-0026" ref-type="ref">26</xref>, <xref rid="cytoa24230-bib-0027" ref-type="ref">27</xref>, <xref rid="cytoa24230-bib-0028" ref-type="ref">28</xref>). However, CD16 expression by HLA&#8208;DR<sup>+</sup> cells could also point to the identification of non&#8208;classical CD14<sup>&#8722;</sup> monocytes (<xref rid="cytoa24230-bib-0029" ref-type="ref">29</xref>). We observed that a small fraction of NKp46<sup>+</sup> cells expressed HLA&#8208;DR in the blood and the tumor tissues but kept HLA&#8208;DR as a lineage marker. Future single&#8208;cell RNA sequencing studies will help determine the nature of these cells and dictate if HLA&#8208;DR should be included in the gating strategy or as an activation marker.</p><fig fig-type="Figure" xml:lang="en" id="cytoa24230-fig-0001" orientation="portrait" position="float"><label>Figure 1</label><caption><p>Gating strategy, NKp46&#8208;based approach and panel performance. (<bold>A</bold>) Gating strategy to identify NK cells in a single&#8208;cell suspension from a representative tumor tissue. Stable acquisition over time is monitored (1), followed by exclusion of debris (2), doublets (3, 4), and autofluorescent cells (5). NK cells were identified as live lymphocytes (6), non&#8208;CD14<sup>+</sup> monocytes (7), non&#8208;CD19<sup>+</sup> B cells (7), non&#8208;CD3<sup>+</sup> T cells (8), non&#8208;CD127<sup>+</sup> innate lymphoid cells 1 (ILC1) (8), and non&#8208;HLA&#8208;DR<sup>+</sup> cells (9). (<bold>B</bold>) To determine whether protein detection is affected by the collagenase Type II&#8208;based tissue digestion protocol, peripheral blood mononuclear cells (PBMC) from healthy donors were treated with 350&#8201;U/ml of collagenase Type II for 30&#8201;min at 37&#176;C. The bivariate dot plots are representing the expression of CD56 and CD16 or NKp46 and CD16 from one healthy donor before or after collagenase digestion. The right graph shows the frequencies of each different highlighted population within the HLA&#8208;DR<sup>&#8722;</sup> cells as depicted in A (<italic toggle="yes">n</italic> = 4, Mann Whitney Test). (<bold>C</bold>) Overview of the 18 phenotypic molecules analyzed within the NKp46<sup>+</sup> cells of the tumor tissue (red) of a representative donor and its matched&#8208;peripheral blood (blue). Central bivariate dot plot shows the gate used to identify NKp46&#8208;expressing cells for both samples. Surrounding histograms or dot plots are showing the expression of the markers for both samples classified in the different categories: activation and co&#8208;activation markers, inhibition and co&#8208;inhibition markers, maturation markers, activation markers and migration and residency markers. As controls, both fluorescence minus one staining (FMOs) (Supporting Information Online Fig. <xref rid="cytoa24230-supitem-0002" ref-type="supplementary-material">S7</xref>), as well as reference populations, which were either CD19<sup>+</sup> B cells (serving as negative expression control) or CD3<sup>+</sup> T cells (serving as positive expression control) from the same tumor tissue, were used.</p></caption><graphic xmlns:xlink="http://www.w3.org/1999/xlink" id="nlm-graphic-3" position="float" orientation="portrait" xlink:href="CYTO-97-1052-g001.jpg"/></fig><p>Human peripheral blood NK cells are typically defined by the relative expression of two different surface markers: CD56 (NCAM), an adhesion molecule that has also been shown to be involved in NK cell activation (<xref rid="cytoa24230-bib-0030" ref-type="ref">30</xref>), and CD16, the low&#8208;affinity Fc receptor known as FcyRIII that binds to the Fc domain of IgG antibodies and induces antibody&#8208;dependent cellular cytotoxicity (ADCC) upon binding (<xref rid="cytoa24230-bib-0031" ref-type="ref">31</xref>). We found that the detected level of CD56 was decreased during the isolation process required to fully dissociate tumor tissue and obtain a single cell suspension (Fig. <xref rid="cytoa24230-fig-0001" ref-type="fig">1B</xref>). This sensitivity to a commonly used collagenase Type II&#8208;based digestion protocol (<xref rid="cytoa24230-bib-0020" ref-type="ref">20</xref>) highlighted that CD56 was not an ideal marker to clearly define NK&#8208;cell subsets in tissues. Likewise, it might also explain the increased frequency of CD56<sup>dim</sup> CD16<sup>&#8722;</sup> NK cells that has been observed in human tissues (<xref rid="cytoa24230-bib-0032" ref-type="ref">32</xref>, <xref rid="cytoa24230-bib-0033" ref-type="ref">33</xref>, <xref rid="cytoa24230-bib-0034" ref-type="ref">34</xref>). As an alternative we have decided to use NKp46, a member of the highly conserved natural cytotoxicity receptor (NCR) family of NK&#8208;activating receptors, which has been proposed to be a unique marker to define NK cells across species (<xref rid="cytoa24230-bib-0035" ref-type="ref">35</xref>) in context of other lineage markers.</p><p>We then compiled a set of 18 biomarkers, which are highly relevant for assessing NK&#8208;cell phenotype and function. First, as NK&#8208;cell activation is regulated by the integration of signals from a wide array of receptors (<xref rid="cytoa24230-bib-0036" ref-type="ref">36</xref>), we included the activating receptors NKG2D and CD244, and the inhibitory receptors CD161 and NKG2A. We also included CD2, a cell adhesion molecule that has been shown to be relevant for activation of NK cells and memory formation (<xref rid="cytoa24230-bib-0037" ref-type="ref">37</xref>, <xref rid="cytoa24230-bib-0038" ref-type="ref">38</xref>).</p><p>We then tested several proteins with inhibitory properties such as PD&#8208;1, Tim3, and TIGIT (<xref rid="cytoa24230-bib-0039" ref-type="ref">39</xref>), but only included TIGIT in the final panel (<xref rid="cytoa24230-bib-0040" ref-type="ref">40</xref>). We found that Tim3 expression was sensitive to collagenase treatment, and, in line with a recent publication we did not observe PD&#8208;1 expression by NK cells (<xref rid="cytoa24230-bib-0041" ref-type="ref">41</xref>).</p><p>We also included markers used to define NK&#8208;cell differentiation (CD57, CD11b, CD27) (<xref rid="cytoa24230-bib-0042" ref-type="ref">42</xref>, <xref rid="cytoa24230-bib-0043" ref-type="ref">43</xref>, <xref rid="cytoa24230-bib-0044" ref-type="ref">44</xref>), activation (CD38, CD25) (<xref rid="cytoa24230-bib-0045" ref-type="ref">45</xref>, <xref rid="cytoa24230-bib-0046" ref-type="ref">46</xref>), and cytotoxic potential (Granzyme B). Ki67 was included as an indicator of cell proliferation. Finally, to assess migratory potential and tissue residence, CD69, CD103, and CX3CR1 were included in this panel along with CD39, a marker of chronic antigen stimulation (<xref rid="cytoa24230-bib-0018" ref-type="ref">18</xref>).</p><p>The performance of the NK panel is displayed in Figure <xref rid="cytoa24230-fig-0001" ref-type="fig">1C</xref>. We found that this combination of markers enabled a thorough phenotypic characterization of NK cells within tumor tissues limited in both size and cell number. Of note, although our panel was developed primarily to assess NK cell phenotype, the expression of most markers could be assessed for CD3<sup>+</sup> T cells, providing additional valuable biological insight (Supporting Information Online Fig. <xref rid="cytoa24230-supitem-0002" ref-type="supplementary-material">S9</xref>).</p></sec><sec id="cytoa24230-sec-0002"><title>Human Samples</title><p>Following approval from the ethical committee of the Institutional Review Board (IRB) of the Fred Hutchinson Cancer Research Center (Seattle USA), fragments of fresh tumor tissue as well as peripheral blood from the same donor were obtained from patients undergoing surgery for a head and neck squamous cell carcinoma in the Department of Otolaryngology, Head and Neck Surgery and Oncology, University of Washington, Seattle, USA.</p></sec><sec id="cytoa24230-sec-0003"><title>Similarity to Other Published <styled-content style="fixed-case" toggle="no">OMIPs</styled-content>
</title><p>While there are other OMIPs that allow for a broad immunophenotyping of NK cells, to date, there is no OMIP specifically designed to deeply profile NK cells isolated from tumor tissues. We included the necessary concomitant assessment of how the tissue digestion protocol affects detection of surface proteins. OMIP&#8208;007 (<xref rid="cytoa24230-bib-0047" ref-type="ref">47</xref>), OMIP&#8208;029 (<xref rid="cytoa24230-bib-0048" ref-type="ref">48</xref>), OMIP&#8208;056 (<xref rid="cytoa24230-bib-0049" ref-type="ref">49</xref>), OMIP&#8208;058 (<xref rid="cytoa24230-bib-0050" ref-type="ref">50</xref>), and OMIP&#8208;064 (<xref rid="cytoa24230-bib-0051" ref-type="ref">51</xref>) focus on phenotypic analysis of human NK cells from peripheral blood, OMIP&#8208;027 (<xref rid="cytoa24230-bib-0052" ref-type="ref">52</xref>) is optimized to assess functional responses of NK cells, and OMIP&#8208;039 (<xref rid="cytoa24230-bib-0053" ref-type="ref">53</xref>) allows distinguishing adaptive from conventional NK cells.</p><p>This 27&#8208;parameter OMIP is optimized for the identification and in&#8208;depth characterization of the NK cell infiltrate within collagenase&#8208;digested human tumor tissue and will be a helpful tool for the study of immune cell function in human tumors as well as other human mucosal tissues.</p></sec><sec id="cytoa24230-sec-0006"><title>Author Contributions</title><p>
<bold>Marie Frutoso:</bold> Conceptualization; data curation; formal analysis; investigation; methodology; visualization; writing&#8208;original draft. <bold>Florian Mair:</bold> Conceptualization; formal analysis; investigation; methodology; visualization; writing&#8208;original draft; writing&#8208;review and editing.</p></sec><sec sec-type="COI-statement" id="cytoa24230-sec-0005"><title>Conflict of Interest</title><p>The authors declare no conflict of interest.</p></sec><sec sec-type="supplementary-material"><title>Supporting information</title><supplementary-material content-type="local-data" id="cytoa24230-supitem-0001" position="float" orientation="portrait"><caption><p>
<bold>Appendix S1</bold> MIFlowCyt: MIFlowCyt&#8208;Compliant Items</p></caption><media xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="CYTO-97-1052-s001.doc" position="float" orientation="portrait"><caption><p>Click here for additional data file.</p></caption></media></supplementary-material><supplementary-material content-type="local-data" id="cytoa24230-supitem-0002" position="float" orientation="portrait"><caption><p>
<bold>Appendix S2</bold> Supporting Information.</p></caption><media xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="CYTO-97-1052-s002.pdf" position="float" orientation="portrait"><caption><p>Click here for additional data file.</p></caption></media></supplementary-material></sec></body><back><ack id="cytoa24230-sec-0004"><title>Acknowledgments</title><p>The authors would like to thank the HIV Vaccine Trial Network for access to their instruments. The authors thank Aaron Tyznik (BD Biosciences) for providing reagents and advice. F.M. is an ISAC Marylou scholar and was supported through The American Association of Immunologists (AAI) Intersect Fellowship Program for Computational Scientists and Immunologists. Grant sponsor: NIH R01Al123323 and U19Al128914.</p></ack><ref-list id="cytoa24230-bibl-0001" content-type="cited-references"><title>Literature Cited</title><ref id="cytoa24230-bib-0001"><label>1</label><mixed-citation publication-type="journal" id="cytoa24230-cit-0001"><string-name name-style="western"><surname>Herberman</surname><given-names>RB</given-names></string-name>, <string-name name-style="western"><surname>Nunn</surname><given-names>ME</given-names></string-name>, <string-name name-style="western"><surname>Holden</surname><given-names>HT</given-names></string-name>, <string-name name-style="western"><surname>Lavrin</surname><given-names>DH</given-names></string-name>. <article-title>Natural cytotoxic reactivity of mouse lymphoid cells against syngeneic and allogeneic tumors. II. Characterization of effector cells</article-title>. <source xml:lang="en">Int J Cancer</source><year>1975</year>;<volume>16</volume>:<fpage>230</fpage>&#8211;<lpage>239</lpage>.<pub-id pub-id-type="pmid">1080480</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1002/ijc.2910160205</pub-id></mixed-citation></ref><ref id="cytoa24230-bib-0002"><label>2</label><mixed-citation publication-type="journal" id="cytoa24230-cit-0002"><string-name name-style="western"><surname>Kiessling</surname><given-names>R</given-names></string-name>, <string-name name-style="western"><surname>Klein</surname><given-names>E</given-names></string-name>, <string-name name-style="western"><surname>Wigzell</surname><given-names>H</given-names></string-name>. <article-title>"Natural" killer cells in the mouse. I. Cytotoxic cells with specificity for mouse Moloney leukemia cells. Specificity and distribution according to genotype</article-title>. <source xml:lang="en">Eur J Immunol</source><year>1975</year>;<volume>5</volume>:<fpage>112</fpage>&#8211;<lpage>117</lpage>.<pub-id pub-id-type="pmid">1234049</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1002/eji.1830050208</pub-id></mixed-citation></ref><ref id="cytoa24230-bib-0003"><label>3</label><mixed-citation publication-type="journal" id="cytoa24230-cit-0003"><string-name name-style="western"><surname>Sathe</surname><given-names>P</given-names></string-name>, <string-name name-style="western"><surname>Delconte</surname><given-names>RB</given-names></string-name>, <string-name name-style="western"><surname>Souza&#8208;Fonseca&#8208;Guimaraes</surname><given-names>F</given-names></string-name>, <string-name name-style="western"><surname>Seillet</surname><given-names>C</given-names></string-name>, <string-name name-style="western"><surname>Chopin</surname><given-names>M</given-names></string-name>, <string-name name-style="western"><surname>Vandenberg</surname><given-names>CJ</given-names></string-name>, <string-name name-style="western"><surname>Rankin</surname><given-names>LC</given-names></string-name>, <string-name name-style="western"><surname>Mielke</surname><given-names>LA</given-names></string-name>, <string-name name-style="western"><surname>Vikstrom</surname><given-names>I</given-names></string-name>, <string-name name-style="western"><surname>Kolesnik</surname><given-names>TB</given-names></string-name>, et al. <article-title>Innate immunodeficiency following genetic ablation of Mcl1 in natural killer cells</article-title>. <source xml:lang="en">Nat Commun</source><year>2014</year>;<volume>5</volume>:<fpage>4539</fpage>.<pub-id pub-id-type="pmid">25119382</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1038/ncomms5539</pub-id></mixed-citation></ref><ref id="cytoa24230-bib-0004"><label>4</label><mixed-citation publication-type="journal" id="cytoa24230-cit-0004"><string-name name-style="western"><surname>Chockley</surname><given-names>PJ</given-names></string-name>, <string-name name-style="western"><surname>Chen</surname><given-names>J</given-names></string-name>, <string-name name-style="western"><surname>Chen</surname><given-names>G</given-names></string-name>, <string-name name-style="western"><surname>Beer</surname><given-names>DG</given-names></string-name>, <string-name name-style="western"><surname>Standiford</surname><given-names>TJ</given-names></string-name>, <string-name name-style="western"><surname>Keshamouni</surname><given-names>VG</given-names></string-name>. <article-title>Epithelial&#8208;mesenchymal transition leads to NK cell&#8208;mediated metastasis&#8208;specific immunosurveillance in lung cancer</article-title>. <source xml:lang="en">J Clin Invest</source><year>2018</year>;<volume>128</volume>:<fpage>1384</fpage>&#8211;<lpage>1396</lpage>.<pub-id pub-id-type="pmid">29324443</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1172/JCI97611</pub-id><pub-id pub-id-type="pmcid">PMC5873856</pub-id></mixed-citation></ref><ref id="cytoa24230-bib-0005"><label>5</label><mixed-citation publication-type="journal" id="cytoa24230-cit-0005"><string-name name-style="western"><surname>Martin&#8208;Fontecha</surname><given-names>A</given-names></string-name>, <string-name name-style="western"><surname>Thomsen</surname><given-names>LL</given-names></string-name>, <string-name name-style="western"><surname>Brett</surname><given-names>S</given-names></string-name>, <string-name name-style="western"><surname>Gerard</surname><given-names>C</given-names></string-name>, <string-name name-style="western"><surname>Lipp</surname><given-names>M</given-names></string-name>, <string-name name-style="western"><surname>Lanzavecchia</surname><given-names>A</given-names></string-name>, <string-name name-style="western"><surname>Sallusto</surname><given-names>F</given-names></string-name>. <article-title>Induced recruitment of NK cells to lymph nodes provides IFN&#8208;gamma for T(H)1 priming</article-title>. <source xml:lang="en">Nat Immunol</source><year>2004</year>;<volume>5</volume>:<fpage>1260</fpage>&#8211;<lpage>1265</lpage>.<pub-id pub-id-type="pmid">15531883</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1038/ni1138</pub-id></mixed-citation></ref><ref id="cytoa24230-bib-0006"><label>6</label><mixed-citation publication-type="journal" id="cytoa24230-cit-0006"><string-name name-style="western"><surname>Krebs</surname><given-names>P</given-names></string-name>, <string-name name-style="western"><surname>Barnes</surname><given-names>MJ</given-names></string-name>, <string-name name-style="western"><surname>Lampe</surname><given-names>K</given-names></string-name>, <string-name name-style="western"><surname>Whitley</surname><given-names>K</given-names></string-name>, <string-name name-style="western"><surname>Bahjat</surname><given-names>KS</given-names></string-name>, <string-name name-style="western"><surname>Beutler</surname><given-names>B</given-names></string-name>, <string-name name-style="western"><surname>Janssen</surname><given-names>E</given-names></string-name>, <string-name name-style="western"><surname>Hoebe</surname><given-names>K</given-names></string-name>. <article-title>NK&#8208;cell&#8208;mediated killing of target cells triggers robust antigen&#8208;specific T&#8208;cell&#8208;mediated and humoral responses</article-title>. <source xml:lang="en">Blood</source><year>2009</year>;<volume>113</volume>:<fpage>6593</fpage>&#8211;<lpage>6602</lpage>.<pub-id pub-id-type="pmid">19406986</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1182/blood-2009-01-201467</pub-id><pub-id pub-id-type="pmcid">PMC2710917</pub-id></mixed-citation></ref><ref id="cytoa24230-bib-0007"><label>7</label><mixed-citation publication-type="journal" id="cytoa24230-cit-0007"><string-name name-style="western"><surname>Barry</surname><given-names>KC</given-names></string-name>, <string-name name-style="western"><surname>Hsu</surname><given-names>J</given-names></string-name>, <string-name name-style="western"><surname>Broz</surname><given-names>ML</given-names></string-name>, <string-name name-style="western"><surname>Cueto</surname><given-names>FJ</given-names></string-name>, <string-name name-style="western"><surname>Binnewies</surname><given-names>M</given-names></string-name>, <string-name name-style="western"><surname>Combes</surname><given-names>AJ</given-names></string-name>, <string-name name-style="western"><surname>Nelson</surname><given-names>AE</given-names></string-name>, <string-name name-style="western"><surname>Loo</surname><given-names>K</given-names></string-name>, <string-name name-style="western"><surname>Kumar</surname><given-names>R</given-names></string-name>, <string-name name-style="western"><surname>Rosenblum</surname><given-names>MD</given-names></string-name>, et al. <article-title>A natural killer&#8208;dendritic cell axis defines checkpoint therapy&#8208;responsive tumor microenvironments</article-title>. <source xml:lang="en">Nat Med</source><year>2018</year>;<volume>24</volume>:<fpage>1178</fpage>&#8211;<lpage>1191</lpage>.<pub-id pub-id-type="pmid">29942093</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1038/s41591-018-0085-8</pub-id><pub-id pub-id-type="pmcid">PMC6475503</pub-id></mixed-citation></ref><ref id="cytoa24230-bib-0008"><label>8</label><mixed-citation publication-type="journal" id="cytoa24230-cit-0008"><string-name name-style="western"><surname>Bottcher</surname><given-names>JP</given-names></string-name>, <string-name name-style="western"><surname>Bonavita</surname><given-names>E</given-names></string-name>, <string-name name-style="western"><surname>Chakravarty</surname><given-names>P</given-names></string-name>, <string-name name-style="western"><surname>Blees</surname><given-names>H</given-names></string-name>, <string-name name-style="western"><surname>Cabeza&#8208;Cabrerizo</surname><given-names>M</given-names></string-name>, <string-name name-style="western"><surname>Sammicheli</surname><given-names>S</given-names></string-name>, <string-name name-style="western"><surname>Rogers</surname><given-names>NC</given-names></string-name>, <string-name name-style="western"><surname>Sahai</surname><given-names>E</given-names></string-name>, <string-name name-style="western"><surname>Zelenay</surname><given-names>S</given-names></string-name>, <string-name name-style="western"><surname>Reis e Sousa</surname><given-names>C</given-names></string-name>. <article-title>NK cells stimulate recruitment of cDC1 into the tumor microenvironment promoting cancer immune control</article-title>. <source xml:lang="en">Cell</source><year>2018</year>;<volume>172</volume>:<fpage>1022</fpage>&#8211;<lpage>1037</lpage>. e14.<pub-id pub-id-type="pmid">29429633</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.cell.2018.01.004</pub-id><pub-id pub-id-type="pmcid">PMC5847168</pub-id></mixed-citation></ref><ref id="cytoa24230-bib-0009"><label>9</label><mixed-citation publication-type="journal" id="cytoa24230-cit-0009"><string-name name-style="western"><surname>Vivier</surname><given-names>E</given-names></string-name>, <string-name name-style="western"><surname>Tomasello</surname><given-names>E</given-names></string-name>, <string-name name-style="western"><surname>Baratin</surname><given-names>M</given-names></string-name>, <string-name name-style="western"><surname>Walzer</surname><given-names>T</given-names></string-name>, <string-name name-style="western"><surname>Ugolini</surname><given-names>S</given-names></string-name>. <article-title>Functions of natural killer cells</article-title>. <source xml:lang="en">Nat Immunol</source><year>2008</year>;<volume>9</volume>:<fpage>503</fpage>&#8211;<lpage>510</lpage>.<pub-id pub-id-type="pmid">18425107</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1038/ni1582</pub-id></mixed-citation></ref><ref id="cytoa24230-bib-0010"><label>10</label><mixed-citation publication-type="journal" id="cytoa24230-cit-0010"><string-name name-style="western"><surname>Stevens</surname><given-names>A</given-names></string-name>, <string-name name-style="western"><surname>Kloter</surname><given-names>I</given-names></string-name>, <string-name name-style="western"><surname>Roggendorf</surname><given-names>W</given-names></string-name>. <article-title>Inflammatory infiltrates and natural killer cell presence in human brain tumors</article-title>. <source xml:lang="en">Cancer</source><year>1988</year>;<volume>61</volume>:<fpage>738</fpage>&#8211;<lpage>743</lpage>.<pub-id pub-id-type="pmid">3338036</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1002/1097-0142(19880215)61:4&lt;738::aid-cncr2820610417&gt;3.0.co;2-e</pub-id></mixed-citation></ref><ref id="cytoa24230-bib-0011"><label>11</label><mixed-citation publication-type="journal" id="cytoa24230-cit-0011"><string-name name-style="western"><surname>Coca</surname><given-names>S</given-names></string-name>, <string-name name-style="western"><surname>Perez&#8208;Piqueras</surname><given-names>J</given-names></string-name>, <string-name name-style="western"><surname>Martinez</surname><given-names>D</given-names></string-name>, <string-name name-style="western"><surname>Colmenarejo</surname><given-names>A</given-names></string-name>, <string-name name-style="western"><surname>Saez</surname><given-names>MA</given-names></string-name>, <string-name name-style="western"><surname>Vallejo</surname><given-names>C</given-names></string-name>, <string-name name-style="western"><surname>Martos</surname><given-names>JA</given-names></string-name>, <string-name name-style="western"><surname>Moreno</surname><given-names>M</given-names></string-name>. <article-title>The prognostic significance of intratumoral natural killer cells in patients with colorectal carcinoma</article-title>. <source xml:lang="en">Cancer</source><year>1997</year>;<volume>79</volume>:<fpage>2320</fpage>&#8211;<lpage>2328</lpage>.<pub-id pub-id-type="pmid">9191519</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1002/(sici)1097-0142(19970615)79:12&lt;2320::aid-cncr5&gt;3.0.co;2-p</pub-id></mixed-citation></ref><ref id="cytoa24230-bib-0012"><label>12</label><mixed-citation publication-type="journal" id="cytoa24230-cit-0012"><string-name name-style="western"><surname>Ishigami</surname><given-names>S</given-names></string-name>, <string-name name-style="western"><surname>Natsugoe</surname><given-names>S</given-names></string-name>, <string-name name-style="western"><surname>Tokuda</surname><given-names>K</given-names></string-name>, <string-name name-style="western"><surname>Nakajo</surname><given-names>A</given-names></string-name>, <string-name name-style="western"><surname>Che</surname><given-names>X</given-names></string-name>, <string-name name-style="western"><surname>Iwashige</surname><given-names>H</given-names></string-name>, <string-name name-style="western"><surname>Aridome</surname><given-names>K</given-names></string-name>, <string-name name-style="western"><surname>Hokita</surname><given-names>S</given-names></string-name>, <string-name name-style="western"><surname>Aikou</surname><given-names>T</given-names></string-name>. <article-title>Prognostic value of intratumoral natural killer cells in gastric carcinoma</article-title>. <source xml:lang="en">Cancer</source><year>2000</year>;<volume>88</volume>:<fpage>577</fpage>&#8211;<lpage>583</lpage>.<pub-id pub-id-type="pmid">10649250</pub-id></mixed-citation></ref><ref id="cytoa24230-bib-0013"><label>13</label><mixed-citation publication-type="journal" id="cytoa24230-cit-0013"><string-name name-style="western"><surname>Villegas</surname><given-names>FR</given-names></string-name>, <string-name name-style="western"><surname>Coca</surname><given-names>S</given-names></string-name>, <string-name name-style="western"><surname>Villarrubia</surname><given-names>VG</given-names></string-name>, <string-name name-style="western"><surname>Jimenez</surname><given-names>R</given-names></string-name>, <string-name name-style="western"><surname>Chillon</surname><given-names>MJ</given-names></string-name>, <string-name name-style="western"><surname>Jareno</surname><given-names>J</given-names></string-name>, <string-name name-style="western"><surname>Zuil</surname><given-names>M</given-names></string-name>, <string-name name-style="western"><surname>Callol</surname><given-names>L</given-names></string-name>. <article-title>Prognostic significance of tumor infiltrating natural killer cells subset CD57 in patients with squamous cell lung cancer</article-title>. <source xml:lang="en">Lung Cancer</source><year>2002</year>;<volume>35</volume>:<fpage>23</fpage>&#8211;<lpage>28</lpage>.<pub-id pub-id-type="pmid">11750709</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/s0169-5002(01)00292-6</pub-id></mixed-citation></ref><ref id="cytoa24230-bib-0014"><label>14</label><mixed-citation publication-type="journal" id="cytoa24230-cit-0014"><string-name name-style="western"><surname>Jin</surname><given-names>S</given-names></string-name>, <string-name name-style="western"><surname>Deng</surname><given-names>Y</given-names></string-name>, <string-name name-style="western"><surname>Hao</surname><given-names>JW</given-names></string-name>, <string-name name-style="western"><surname>Li</surname><given-names>Y</given-names></string-name>, <string-name name-style="western"><surname>Liu</surname><given-names>B</given-names></string-name>, <string-name name-style="western"><surname>Yu</surname><given-names>Y</given-names></string-name>, <string-name name-style="western"><surname>Shi</surname><given-names>FD</given-names></string-name>, <string-name name-style="western"><surname>Zhou</surname><given-names>QH</given-names></string-name>. <article-title>NK cell phenotypic modulation in lung cancer environment</article-title>. <source xml:lang="en">PLoS One</source><year>2014</year>;<volume>9</volume>:<elocation-id>e109976</elocation-id>.<pub-id pub-id-type="pmid">25299645</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1371/journal.pone.0109976</pub-id><pub-id pub-id-type="pmcid">PMC4192363</pub-id></mixed-citation></ref><ref id="cytoa24230-bib-0015"><label>15</label><mixed-citation publication-type="journal" id="cytoa24230-cit-0015"><string-name name-style="western"><surname>Morvan</surname><given-names>MG</given-names></string-name>, <string-name name-style="western"><surname>Lanier</surname><given-names>LL</given-names></string-name>. <article-title>NK cells and cancer: You can teach innate cells new tricks</article-title>. <source xml:lang="en">Nat Rev Cancer</source><year>2016</year>;<volume>16</volume>:<fpage>7</fpage>&#8211;<lpage>19</lpage>.<pub-id pub-id-type="pmid">26694935</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1038/nrc.2015.5</pub-id></mixed-citation></ref><ref id="cytoa24230-bib-0016"><label>16</label><mixed-citation publication-type="journal" id="cytoa24230-cit-0016"><string-name name-style="western"><surname>Barrow</surname><given-names>AD</given-names></string-name>, <string-name name-style="western"><surname>Colonna</surname><given-names>M</given-names></string-name>. <article-title>Exploiting NK cell surveillance pathways for cancer therapy</article-title>. <source xml:lang="en">Cancers (Basel)</source><year>2019</year>;<volume>11</volume>(<issue>1</issue>):<fpage>55</fpage>.<pub-id pub-id-type="doi" assigning-authority="pmc">10.3390/cancers11010055</pub-id><pub-id pub-id-type="pmcid">PMC6356551</pub-id><pub-id pub-id-type="pmid">30626155</pub-id></mixed-citation></ref><ref id="cytoa24230-bib-0017"><label>17</label><mixed-citation publication-type="journal" id="cytoa24230-cit-0017"><string-name name-style="western"><surname>Habif</surname><given-names>G</given-names></string-name>, <string-name name-style="western"><surname>Crinier</surname><given-names>A</given-names></string-name>, <string-name name-style="western"><surname>Andre</surname><given-names>P</given-names></string-name>, <string-name name-style="western"><surname>Vivier</surname><given-names>E</given-names></string-name>, <string-name name-style="western"><surname>Narni&#8208;Mancinelli</surname><given-names>E</given-names></string-name>. <article-title>Targeting natural killer cells in solid tumors</article-title>. <source xml:lang="en">Cell Mol Immunol</source><year>2019</year>;<volume>16</volume>:<fpage>415</fpage>&#8211;<lpage>422</lpage>.<pub-id pub-id-type="pmid">30911118</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1038/s41423-019-0224-2</pub-id><pub-id pub-id-type="pmcid">PMC6474204</pub-id></mixed-citation></ref><ref id="cytoa24230-bib-0018"><label>18</label><mixed-citation publication-type="journal" id="cytoa24230-cit-0018"><string-name name-style="western"><surname>Souza&#8208;Fonseca&#8208;Guimaraes</surname><given-names>F</given-names></string-name>, <string-name name-style="western"><surname>Cursons</surname><given-names>J</given-names></string-name>, <string-name name-style="western"><surname>Huntington</surname><given-names>ND</given-names></string-name>. <article-title>The emergence of natural killer cells as a major target in cancer immunotherapy</article-title>. <source xml:lang="en">Trends Immunol</source><year>2019</year>;<volume>40</volume>:<fpage>142</fpage>&#8211;<lpage>158</lpage>.<pub-id pub-id-type="pmid">30639050</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.it.2018.12.003</pub-id></mixed-citation></ref><ref id="cytoa24230-bib-0019"><label>19</label><mixed-citation publication-type="journal" id="cytoa24230-cit-0019"><string-name name-style="western"><surname>Shacklett</surname><given-names>BL</given-names></string-name>, <string-name name-style="western"><surname>Yang</surname><given-names>O</given-names></string-name>, <string-name name-style="western"><surname>Hausner</surname><given-names>MA</given-names></string-name>, <string-name name-style="western"><surname>Elliott</surname><given-names>J</given-names></string-name>, <string-name name-style="western"><surname>Hultin</surname><given-names>L</given-names></string-name>, <string-name name-style="western"><surname>Price</surname><given-names>C</given-names></string-name>, <string-name name-style="western"><surname>Fuerst</surname><given-names>M</given-names></string-name>, <string-name name-style="western"><surname>Matud</surname><given-names>J</given-names></string-name>, <string-name name-style="western"><surname>Hultin</surname><given-names>P</given-names></string-name>, <string-name name-style="western"><surname>Cox</surname><given-names>C</given-names></string-name>, et al. <article-title>Optimization of methods to assess human mucosal T&#8208;cell responses to HIV infection</article-title>. <source xml:lang="en">J Immunol Methods</source><year>2003</year>;<volume>279</volume>:<fpage>17</fpage>&#8211;<lpage>31</lpage>.<pub-id pub-id-type="pmid">12969544</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/s0022-1759(03)00255-2</pub-id></mixed-citation></ref><ref id="cytoa24230-bib-0020"><label>20</label><mixed-citation publication-type="journal" id="cytoa24230-cit-0020"><string-name name-style="western"><surname>McKinnon</surname><given-names>LR</given-names></string-name>, <string-name name-style="western"><surname>Hughes</surname><given-names>SM</given-names></string-name>, <string-name name-style="western"><surname>De Rosa</surname><given-names>SC</given-names></string-name>, <string-name name-style="western"><surname>Martinson</surname><given-names>JA</given-names></string-name>, <string-name name-style="western"><surname>Plants</surname><given-names>J</given-names></string-name>, <string-name name-style="western"><surname>Brady</surname><given-names>KE</given-names></string-name>, <string-name name-style="western"><surname>Gumbi</surname><given-names>PP</given-names></string-name>, <string-name name-style="western"><surname>Adams</surname><given-names>DJ</given-names></string-name>, <string-name name-style="western"><surname>Vojtech</surname><given-names>L</given-names></string-name>, <string-name name-style="western"><surname>Galloway</surname><given-names>CG</given-names></string-name>, et al. <article-title>Optimizing viable leukocyte sampling from the female genital tract for clinical trials: An international multi&#8208;site study</article-title>. <source xml:lang="en">PLoS One</source><year>2014</year>;<volume>9</volume>:<elocation-id>e85675</elocation-id>.<pub-id pub-id-type="pmid">24454917</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1371/journal.pone.0085675</pub-id><pub-id pub-id-type="pmcid">PMC3893217</pub-id></mixed-citation></ref><ref id="cytoa24230-bib-0021"><label>21</label><mixed-citation publication-type="journal" id="cytoa24230-cit-0021"><string-name name-style="western"><surname>Leelatian</surname><given-names>N</given-names></string-name>, <string-name name-style="western"><surname>Doxie</surname><given-names>DB</given-names></string-name>, <string-name name-style="western"><surname>Greenplate</surname><given-names>AR</given-names></string-name>, <string-name name-style="western"><surname>Sinnaeve</surname><given-names>J</given-names></string-name>, <string-name name-style="western"><surname>Ihrie</surname><given-names>RA</given-names></string-name>, <string-name name-style="western"><surname>Irish</surname><given-names>JM</given-names></string-name>. <article-title>Preparing viable single cells from human tissue and tumors for cytomic analysis</article-title>. <source xml:lang="en">Curr Protoc Mol Biol</source><year>2017</year>;<volume>118</volume>:<fpage>25C 1 1</fpage>&#8211;<lpage>25C 1 23</lpage>.<pub-id pub-id-type="doi" assigning-authority="pmc">10.1002/cpmb.37</pub-id><pub-id pub-id-type="pmcid">PMC5518778</pub-id><pub-id pub-id-type="pmid">28369679</pub-id></mixed-citation></ref><ref id="cytoa24230-bib-0022"><label>22</label><mixed-citation publication-type="journal" id="cytoa24230-cit-0022"><string-name name-style="western"><surname>Bendall</surname><given-names>SC</given-names></string-name>, <string-name name-style="western"><surname>Nolan</surname><given-names>GP</given-names></string-name>, <string-name name-style="western"><surname>Roederer</surname><given-names>M</given-names></string-name>, <string-name name-style="western"><surname>Chattopadhyay</surname><given-names>PK</given-names></string-name>. <article-title>A deep profiler' guide to cytometry</article-title>. <source xml:lang="en">Trends Immunol</source><year>2012</year>;<volume>33</volume>:<fpage>323</fpage>&#8211;<lpage>332</lpage>.<pub-id pub-id-type="pmid">22476049</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.it.2012.02.010</pub-id><pub-id pub-id-type="pmcid">PMC3383392</pub-id></mixed-citation></ref><ref id="cytoa24230-bib-0023"><label>23</label><mixed-citation publication-type="journal" id="cytoa24230-cit-0023"><string-name name-style="western"><surname>Slichter</surname><given-names>CK</given-names></string-name>, <string-name name-style="western"><surname>McDavid</surname><given-names>A</given-names></string-name>, <string-name name-style="western"><surname>Miller</surname><given-names>HW</given-names></string-name>, <string-name name-style="western"><surname>Finak</surname><given-names>G</given-names></string-name>, <string-name name-style="western"><surname>Seymour</surname><given-names>BJ</given-names></string-name>, <string-name name-style="western"><surname>McNevin</surname><given-names>JP</given-names></string-name>, <string-name name-style="western"><surname>Diaz</surname><given-names>G</given-names></string-name>, <string-name name-style="western"><surname>Czartoski</surname><given-names>JL</given-names></string-name>, <string-name name-style="western"><surname>McElrath</surname><given-names>MJ</given-names></string-name>, <string-name name-style="western"><surname>Gottardo</surname><given-names>R</given-names></string-name>, et al. <article-title>Distinct activation thresholds of human conventional and innate&#8208;like memory T cells</article-title>. <source xml:lang="en">JCI Insight</source><year>2016</year>;<volume>1</volume>:<fpage>e86292</fpage>.<pub-id pub-id-type="pmid">27331143</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1172/jci.insight.86292</pub-id><pub-id pub-id-type="pmcid">PMC4912124</pub-id></mixed-citation></ref><ref id="cytoa24230-bib-0024"><label>24</label><mixed-citation publication-type="journal" id="cytoa24230-cit-0024"><string-name name-style="western"><surname>Woodward Davis</surname><given-names>AS</given-names></string-name>, <string-name name-style="western"><surname>Roozen</surname><given-names>HN</given-names></string-name>, <string-name name-style="western"><surname>Dufort</surname><given-names>MJ</given-names></string-name>, <string-name name-style="western"><surname>DeBerg</surname><given-names>HA</given-names></string-name>, <string-name name-style="western"><surname>Delaney</surname><given-names>MA</given-names></string-name>, <string-name name-style="western"><surname>Mair</surname><given-names>F</given-names></string-name>, <string-name name-style="western"><surname>Erickson</surname><given-names>JR</given-names></string-name>, <string-name name-style="western"><surname>Slichter</surname><given-names>CK</given-names></string-name>, <string-name name-style="western"><surname>Berkson</surname><given-names>JD</given-names></string-name>, <string-name name-style="western"><surname>Klock</surname><given-names>AM</given-names></string-name>, et al. <article-title>The human tissue&#8208;resident CCR5(+) T cell compartment maintains protective and functional properties during inflammation</article-title>. <source xml:lang="en">Sci Transl Med</source><year>2019</year>:<volume>11</volume>;<fpage>521</fpage>.<pub-id pub-id-type="doi" assigning-authority="pmc">10.1126/scitranslmed.aaw8718</pub-id><pub-id pub-id-type="pmcid">PMC7416666</pub-id><pub-id pub-id-type="pmid">31801887</pub-id></mixed-citation></ref><ref id="cytoa24230-bib-0025"><label>25</label><mixed-citation publication-type="journal" id="cytoa24230-cit-0025"><string-name name-style="western"><surname>Ferenczi</surname><given-names>K</given-names></string-name>, <string-name name-style="western"><surname>Burack</surname><given-names>L</given-names></string-name>, <string-name name-style="western"><surname>Pope</surname><given-names>M</given-names></string-name>, <string-name name-style="western"><surname>Krueger</surname><given-names>JG</given-names></string-name>, <string-name name-style="western"><surname>Austin</surname><given-names>LM</given-names></string-name>. <article-title>CD69, HLA&#8208;DR and the IL&#8208;2R identify persistently activated T cells in psoriasis vulgaris lesional skin: Blood and skin comparisons by flow cytometry</article-title>. <source xml:lang="en">J Autoimmun</source><year>2000</year>;<volume>14</volume>:<fpage>63</fpage>&#8211;<lpage>78</lpage>.<pub-id pub-id-type="pmid">10648117</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1006/jaut.1999.0343</pub-id></mixed-citation></ref><ref id="cytoa24230-bib-0026"><label>26</label><mixed-citation publication-type="journal" id="cytoa24230-cit-0026"><string-name name-style="western"><surname>Evans</surname><given-names>JH</given-names></string-name>, <string-name name-style="western"><surname>Horowitz</surname><given-names>A</given-names></string-name>, <string-name name-style="western"><surname>Mehrabi</surname><given-names>M</given-names></string-name>, <string-name name-style="western"><surname>Wise</surname><given-names>EL</given-names></string-name>, <string-name name-style="western"><surname>Pease</surname><given-names>JE</given-names></string-name>, <string-name name-style="western"><surname>Riley</surname><given-names>EM</given-names></string-name>, <string-name name-style="western"><surname>Davis</surname><given-names>DM</given-names></string-name>. <article-title>A distinct subset of human NK cells expressing HLA&#8208;DR expand in response to IL&#8208;2 and can aid immune responses to BCG</article-title>. <source xml:lang="en">Eur J Immunol</source><year>2011</year>;<volume>41</volume>:<fpage>1924</fpage>&#8211;<lpage>1933</lpage>.<pub-id pub-id-type="pmid">21491418</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1002/eji.201041180</pub-id><pub-id pub-id-type="pmcid">PMC3549558</pub-id></mixed-citation></ref><ref id="cytoa24230-bib-0027"><label>27</label><mixed-citation publication-type="journal" id="cytoa24230-cit-0027"><string-name name-style="western"><surname>Erokhina</surname><given-names>SA</given-names></string-name>, <string-name name-style="western"><surname>Streltsova</surname><given-names>MA</given-names></string-name>, <string-name name-style="western"><surname>Kanevskiy</surname><given-names>LM</given-names></string-name>, <string-name name-style="western"><surname>Telford</surname><given-names>WG</given-names></string-name>, <string-name name-style="western"><surname>Sapozhnikov</surname><given-names>AM</given-names></string-name>, <string-name name-style="western"><surname>Kovalenko</surname><given-names>EI</given-names></string-name>. <article-title>HLA&#8208;DR(+) NK cells are mostly characterized by less mature phenotype and high functional activity</article-title>. <source xml:lang="en">Immunol Cell Biol</source><year>2018</year>;<volume>96</volume>:<fpage>212</fpage>&#8211;<lpage>228</lpage>.<pub-id pub-id-type="pmid">29363179</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1111/imcb.1032</pub-id><pub-id pub-id-type="pmcid">PMC8063572</pub-id></mixed-citation></ref><ref id="cytoa24230-bib-0028"><label>28</label><mixed-citation publication-type="journal" id="cytoa24230-cit-0028"><string-name name-style="western"><surname>Dutertre</surname><given-names>CA</given-names></string-name>, <string-name name-style="western"><surname>Becht</surname><given-names>E</given-names></string-name>, <string-name name-style="western"><surname>Irac</surname><given-names>SE</given-names></string-name>, <string-name name-style="western"><surname>Khalilnezhad</surname><given-names>A</given-names></string-name>, <string-name name-style="western"><surname>Narang</surname><given-names>V</given-names></string-name>, <string-name name-style="western"><surname>Khalilnezhad</surname><given-names>S</given-names></string-name>, <string-name name-style="western"><surname>Ng</surname><given-names>PY</given-names></string-name>, <string-name name-style="western"><surname>van den Hoogen</surname><given-names>LL</given-names></string-name>, <string-name name-style="western"><surname>Leong</surname><given-names>JY</given-names></string-name>, <string-name name-style="western"><surname>Lee</surname><given-names>B</given-names></string-name>, et al. <article-title>Single&#8208;cell analysis of human mononuclear phagocytes reveals subset&#8208;defining markers and identifies circulating inflammatory dendritic cells</article-title>. <source xml:lang="en">Immunity</source><year>2019</year>;<volume>51</volume>:<fpage>573</fpage>&#8211;<lpage>589</lpage>. e8.<pub-id pub-id-type="pmid">31474513</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.immuni.2019.08.008</pub-id></mixed-citation></ref><ref id="cytoa24230-bib-0029"><label>29</label><mixed-citation publication-type="journal" id="cytoa24230-cit-0029"><string-name name-style="western"><surname>Mukherjee</surname><given-names>R</given-names></string-name>, <string-name name-style="western"><surname>Kanti Barman</surname><given-names>P</given-names></string-name>, <string-name name-style="western"><surname>Kumar Thatoi</surname><given-names>P</given-names></string-name>, <string-name name-style="western"><surname>Tripathy</surname><given-names>R</given-names></string-name>, <string-name name-style="western"><surname>Kumar Das</surname><given-names>B</given-names></string-name>, <string-name name-style="western"><surname>Ravindran</surname><given-names>B</given-names></string-name>. <article-title>Non&#8208;classical monocytes display inflammatory features: Validation in sepsis and systemic lupus erythematous</article-title>. <source xml:lang="en">Sci Rep</source><year>2015</year>;<volume>5</volume>:<elocation-id>13886</elocation-id>.<pub-id pub-id-type="pmid">26358827</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1038/srep13886</pub-id><pub-id pub-id-type="pmcid">PMC4566081</pub-id></mixed-citation></ref><ref id="cytoa24230-bib-0030"><label>30</label><mixed-citation publication-type="journal" id="cytoa24230-cit-0030"><string-name name-style="western"><surname>Van Acker</surname><given-names>HH</given-names></string-name>, <string-name name-style="western"><surname>Capsomidis</surname><given-names>A</given-names></string-name>, <string-name name-style="western"><surname>Smits</surname><given-names>EL</given-names></string-name>, <string-name name-style="western"><surname>Van Tendeloo</surname><given-names>VF</given-names></string-name>. <article-title>CD56 in the immune system: More than a marker for cytotoxicity?</article-title><source xml:lang="en">Front Immunol</source><year>2017</year>;<volume>8</volume>:<fpage>892</fpage>.<pub-id pub-id-type="pmid">28791027</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.3389/fimmu.2017.00892</pub-id><pub-id pub-id-type="pmcid">PMC5522883</pub-id></mixed-citation></ref><ref id="cytoa24230-bib-0031"><label>31</label><mixed-citation publication-type="journal" id="cytoa24230-cit-0031"><string-name name-style="western"><surname>Caligiuri</surname><given-names>MA</given-names></string-name>. <article-title>Human natural killer cells</article-title>. <source xml:lang="en">Blood</source><year>2008</year>;<volume>112</volume>:<fpage>461</fpage>&#8211;<lpage>469</lpage>.<pub-id pub-id-type="pmid">18650461</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1182/blood-2007-09-077438</pub-id><pub-id pub-id-type="pmcid">PMC2481557</pub-id></mixed-citation></ref><ref id="cytoa24230-bib-0032"><label>32</label><mixed-citation publication-type="journal" id="cytoa24230-cit-0032"><string-name name-style="western"><surname>Mamessier</surname><given-names>E</given-names></string-name>, <string-name name-style="western"><surname>Pradel</surname><given-names>LC</given-names></string-name>, <string-name name-style="western"><surname>Thibult</surname><given-names>ML</given-names></string-name>, <string-name name-style="western"><surname>Drevet</surname><given-names>C</given-names></string-name>, <string-name name-style="western"><surname>Zouine</surname><given-names>A</given-names></string-name>, <string-name name-style="western"><surname>Jacquemier</surname><given-names>J</given-names></string-name>, <string-name name-style="western"><surname>Houvenaeghel</surname><given-names>G</given-names></string-name>, <string-name name-style="western"><surname>Bertucci</surname><given-names>F</given-names></string-name>, <string-name name-style="western"><surname>Birnbaum</surname><given-names>D</given-names></string-name>, <string-name name-style="western"><surname>Olive</surname><given-names>D</given-names></string-name>. <article-title>Peripheral blood NK cells from breast cancer patients are tumor&#8208;induced composite subsets</article-title>. <source xml:lang="en">J Immunol</source><year>2013</year>;<volume>190</volume>:<fpage>2424</fpage>&#8211;<lpage>2436</lpage>.<pub-id pub-id-type="pmid">23359508</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.4049/jimmunol.1200140</pub-id></mixed-citation></ref><ref id="cytoa24230-bib-0033"><label>33</label><mixed-citation publication-type="journal" id="cytoa24230-cit-0033"><string-name name-style="western"><surname>Marquardt</surname><given-names>NSM</given-names></string-name>, <string-name name-style="western"><surname>Mold</surname><given-names>JE</given-names></string-name>, <string-name name-style="western"><surname>H&#229;rd</surname><given-names>J</given-names></string-name>, <string-name name-style="western"><surname>Kek&#228;l&#228;inen</surname><given-names>E</given-names></string-name>, <string-name name-style="western"><surname>Buggert</surname><given-names>M</given-names></string-name>, <string-name name-style="western"><surname>Nguyen</surname><given-names>S</given-names></string-name>, <string-name name-style="western"><surname>Wilson</surname><given-names>JN</given-names></string-name>, <string-name name-style="western"><surname>Al&#8208;Ameri</surname><given-names>M</given-names></string-name>, <string-name name-style="western"><surname>Ljunggren</surname><given-names>HG</given-names></string-name>, <string-name name-style="western"><surname>Micha&#235;lsson</surname><given-names>J</given-names></string-name>. <article-title>High&#8208;dimensional analysis reveals a distinct population of adaptive&#8208;like tissue&#8208;resident NK cells in human lung</article-title>. <source xml:lang="en">bioRxiv</source><year>2019</year><pub-id pub-id-type="doi">10.1101/2019.12.20.883785</pub-id>.</mixed-citation></ref><ref id="cytoa24230-bib-0034"><label>34</label><mixed-citation publication-type="journal" id="cytoa24230-cit-0034"><string-name name-style="western"><surname>Dogra</surname><given-names>P</given-names></string-name>, <string-name name-style="western"><surname>Rancan</surname><given-names>C</given-names></string-name>, <string-name name-style="western"><surname>Ma</surname><given-names>W</given-names></string-name>, <string-name name-style="western"><surname>Toth</surname><given-names>M</given-names></string-name>, <string-name name-style="western"><surname>Senda</surname><given-names>T</given-names></string-name>, <string-name name-style="western"><surname>Carpenter</surname><given-names>DJ</given-names></string-name>, <string-name name-style="western"><surname>Kubota</surname><given-names>M</given-names></string-name>, <string-name name-style="western"><surname>Matsumoto</surname><given-names>R</given-names></string-name>, <string-name name-style="western"><surname>Thapa</surname><given-names>P</given-names></string-name>, <string-name name-style="western"><surname>Szabo</surname><given-names>PA</given-names></string-name>, et al. <article-title>Tissue determinants of human NK cell development, function, and residence</article-title>. <source xml:lang="en">Cell</source><year>2020</year>;<volume>180</volume>:<fpage>749</fpage>&#8211;<lpage>763</lpage>. e13.<pub-id pub-id-type="pmid">32059780</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.cell.2020.01.022</pub-id><pub-id pub-id-type="pmcid">PMC7194029</pub-id></mixed-citation></ref><ref id="cytoa24230-bib-0035"><label>35</label><mixed-citation publication-type="journal" id="cytoa24230-cit-0035"><string-name name-style="western"><surname>Walzer</surname><given-names>T</given-names></string-name>, <string-name name-style="western"><surname>Jaeger</surname><given-names>S</given-names></string-name>, <string-name name-style="western"><surname>Chaix</surname><given-names>J</given-names></string-name>, <string-name name-style="western"><surname>Vivier</surname><given-names>E</given-names></string-name>. <article-title>Natural killer cells: From CD3(&#8722;)NKp46(+) to post&#8208;genomics meta&#8208;analyses</article-title>. <source xml:lang="en">Curr Opin Immunol</source><year>2007</year>;<volume>19</volume>:<fpage>365</fpage>&#8211;<lpage>372</lpage>.<pub-id pub-id-type="pmid">17442558</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.coi.2007.04.004</pub-id></mixed-citation></ref><ref id="cytoa24230-bib-0036"><label>36</label><mixed-citation publication-type="journal" id="cytoa24230-cit-0036"><string-name name-style="western"><surname>Lanier</surname><given-names>LL</given-names></string-name>. <article-title>Up on the tightrope: Natural killer cell activation and inhibition</article-title>. <source xml:lang="en">Nat Immunol</source><year>2008</year>;<volume>9</volume>:<fpage>495</fpage>&#8211;<lpage>502</lpage>.<pub-id pub-id-type="pmid">18425106</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1038/ni1581</pub-id><pub-id pub-id-type="pmcid">PMC2669298</pub-id></mixed-citation></ref><ref id="cytoa24230-bib-0037"><label>37</label><mixed-citation publication-type="journal" id="cytoa24230-cit-0037"><string-name name-style="western"><surname>Liu</surname><given-names>LL</given-names></string-name>, <string-name name-style="western"><surname>Landskron</surname><given-names>J</given-names></string-name>, <string-name name-style="western"><surname>Ask</surname><given-names>EH</given-names></string-name>, <string-name name-style="western"><surname>Enqvist</surname><given-names>M</given-names></string-name>, <string-name name-style="western"><surname>Sohlberg</surname><given-names>E</given-names></string-name>, <string-name name-style="western"><surname>Traherne</surname><given-names>JA</given-names></string-name>, <string-name name-style="western"><surname>Hammer</surname><given-names>Q</given-names></string-name>, <string-name name-style="western"><surname>Goodridge</surname><given-names>JP</given-names></string-name>, <string-name name-style="western"><surname>Larsson</surname><given-names>S</given-names></string-name>, <string-name name-style="western"><surname>Jayaraman</surname><given-names>J</given-names></string-name>, et al. <article-title>Critical role of CD2 co&#8208;stimulation in adaptive natural killer cell responses revealed in NKG2C&#8208;deficient humans</article-title>. <source xml:lang="en">Cell Rep</source><year>2016</year>;<volume>15</volume>:<fpage>1088</fpage>&#8211;<lpage>1099</lpage>.<pub-id pub-id-type="pmid">27117418</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.celrep.2016.04.005</pub-id><pub-id pub-id-type="pmcid">PMC4858565</pub-id></mixed-citation></ref><ref id="cytoa24230-bib-0038"><label>38</label><mixed-citation publication-type="journal" id="cytoa24230-cit-0038"><string-name name-style="western"><surname>Geary</surname><given-names>CD</given-names></string-name>, <string-name name-style="western"><surname>Sun</surname><given-names>JC</given-names></string-name>. <article-title>Memory responses of natural killer cells</article-title>. <source xml:lang="en">Semin Immunol</source><year>2017</year>;<volume>31</volume>:<fpage>11</fpage>&#8211;<lpage>19</lpage>.<pub-id pub-id-type="pmid">28863960</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.smim.2017.08.012</pub-id><pub-id pub-id-type="pmcid">PMC5724965</pub-id></mixed-citation></ref><ref id="cytoa24230-bib-0039"><label>39</label><mixed-citation publication-type="journal" id="cytoa24230-cit-0039"><string-name name-style="western"><surname>Sun</surname><given-names>H</given-names></string-name>, <string-name name-style="western"><surname>Sun</surname><given-names>C</given-names></string-name>. <article-title>The rise of NK cell checkpoints as promising therapeutic targets in cancer immunotherapy</article-title>. <source xml:lang="en">Front Immunol</source><year>2019</year>;<volume>10</volume>:<fpage>2354</fpage>.<pub-id pub-id-type="pmid">31681269</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.3389/fimmu.2019.02354</pub-id><pub-id pub-id-type="pmcid">PMC6812684</pub-id></mixed-citation></ref><ref id="cytoa24230-bib-0040"><label>40</label><mixed-citation publication-type="journal" id="cytoa24230-cit-0040"><string-name name-style="western"><surname>Stanietsky</surname><given-names>N</given-names></string-name>, <string-name name-style="western"><surname>Simic</surname><given-names>H</given-names></string-name>, <string-name name-style="western"><surname>Arapovic</surname><given-names>J</given-names></string-name>, <string-name name-style="western"><surname>Toporik</surname><given-names>A</given-names></string-name>, <string-name name-style="western"><surname>Levy</surname><given-names>O</given-names></string-name>, <string-name name-style="western"><surname>Novik</surname><given-names>A</given-names></string-name>, <string-name name-style="western"><surname>Levine</surname><given-names>Z</given-names></string-name>, <string-name name-style="western"><surname>Beiman</surname><given-names>M</given-names></string-name>, <string-name name-style="western"><surname>Dassa</surname><given-names>L</given-names></string-name>, <string-name name-style="western"><surname>Achdout</surname><given-names>H</given-names></string-name>, et al. <article-title>The interaction of TIGIT with PVR and PVRL2 inhibits human NK cell cytotoxicity</article-title>. <source xml:lang="en">Proc Natl Acad Sci U S A</source><year>2009</year>;<volume>106</volume>:<fpage>17858</fpage>&#8211;<lpage>17863</lpage>.<pub-id pub-id-type="pmid">19815499</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1073/pnas.0903474106</pub-id><pub-id pub-id-type="pmcid">PMC2764881</pub-id></mixed-citation></ref><ref id="cytoa24230-bib-0041"><label>41</label><mixed-citation publication-type="journal" id="cytoa24230-cit-0041"><string-name name-style="western"><surname>Judge</surname><given-names>SJ</given-names></string-name>, <string-name name-style="western"><surname>Dunai</surname><given-names>C</given-names></string-name>, <string-name name-style="western"><surname>Aguilar</surname><given-names>EG</given-names></string-name>, <string-name name-style="western"><surname>Vick</surname><given-names>SC</given-names></string-name>, <string-name name-style="western"><surname>Sturgill</surname><given-names>IR</given-names></string-name>, <string-name name-style="western"><surname>Khuat</surname><given-names>LT</given-names></string-name>, <string-name name-style="western"><surname>Stoffel</surname><given-names>KM</given-names></string-name>, <string-name name-style="western"><surname>Van Dyke</surname><given-names>J</given-names></string-name>, <string-name name-style="western"><surname>Longo</surname><given-names>DL</given-names></string-name>, <string-name name-style="western"><surname>Darrow</surname><given-names>MA</given-names></string-name>, et al. <article-title>Minimal PD&#8208;1 expression in mouse and human NK cells under diverse conditions</article-title>. <source xml:lang="en">J Clin Invest</source><year>2020</year>;<volume>130</volume>:<fpage>3051</fpage>&#8211;<lpage>3068</lpage>.<pub-id pub-id-type="pmid">32134744</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1172/JCI133353</pub-id><pub-id pub-id-type="pmcid">PMC7260004</pub-id></mixed-citation></ref><ref id="cytoa24230-bib-0042"><label>42</label><mixed-citation publication-type="journal" id="cytoa24230-cit-0042"><string-name name-style="western"><surname>Freud</surname><given-names>AG</given-names></string-name>, <string-name name-style="western"><surname>Yokohama</surname><given-names>A</given-names></string-name>, <string-name name-style="western"><surname>Becknell</surname><given-names>B</given-names></string-name>, <string-name name-style="western"><surname>Lee</surname><given-names>MT</given-names></string-name>, <string-name name-style="western"><surname>Mao</surname><given-names>HC</given-names></string-name>, <string-name name-style="western"><surname>Ferketich</surname><given-names>AK</given-names></string-name>, <string-name name-style="western"><surname>Caligiuri</surname><given-names>MA</given-names></string-name>. <article-title>Evidence for discrete stages of human natural killer cell differentiation in vivo</article-title>. <source xml:lang="en">J Exp Med</source><year>2006</year>;<volume>203</volume>:<fpage>1033</fpage>&#8211;<lpage>1043</lpage>.<pub-id pub-id-type="pmid">16606675</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1084/jem.20052507</pub-id><pub-id pub-id-type="pmcid">PMC2118285</pub-id></mixed-citation></ref><ref id="cytoa24230-bib-0043"><label>43</label><mixed-citation publication-type="journal" id="cytoa24230-cit-0043"><string-name name-style="western"><surname>Hayakawa</surname><given-names>Y</given-names></string-name>, <string-name name-style="western"><surname>Smyth</surname><given-names>MJ</given-names></string-name>. <article-title>CD27 dissects mature NK cells into two subsets with distinct responsiveness and migratory capacity</article-title>. <source xml:lang="en">J Immunol</source><year>2006</year>;<volume>176</volume>:<fpage>1517</fpage>&#8211;<lpage>1524</lpage>.<pub-id pub-id-type="pmid">16424180</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.4049/jimmunol.176.3.1517</pub-id></mixed-citation></ref><ref id="cytoa24230-bib-0044"><label>44</label><mixed-citation publication-type="journal" id="cytoa24230-cit-0044"><string-name name-style="western"><surname>Bjorkstrom</surname><given-names>NK</given-names></string-name>, <string-name name-style="western"><surname>Riese</surname><given-names>P</given-names></string-name>, <string-name name-style="western"><surname>Heuts</surname><given-names>F</given-names></string-name>, <string-name name-style="western"><surname>Andersson</surname><given-names>S</given-names></string-name>, <string-name name-style="western"><surname>Fauriat</surname><given-names>C</given-names></string-name>, <string-name name-style="western"><surname>Ivarsson</surname><given-names>MA</given-names></string-name>, <string-name name-style="western"><surname>Bjorklund</surname><given-names>AT</given-names></string-name>, <string-name name-style="western"><surname>Flodstrom&#8208;Tullberg</surname><given-names>M</given-names></string-name>, <string-name name-style="western"><surname>Michaelsson</surname><given-names>J</given-names></string-name>, <string-name name-style="western"><surname>Rottenberg</surname><given-names>ME</given-names></string-name>, et al. <article-title>Expression patterns of NKG2A, KIR, and CD57 define a process of CD56dim NK&#8208;cell differentiation uncoupled from NK&#8208;cell education</article-title>. <source xml:lang="en">Blood</source><year>2010</year>;<volume>116</volume>:<fpage>3853</fpage>&#8211;<lpage>3864</lpage>.<pub-id pub-id-type="pmid">20696944</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1182/blood-2010-04-281675</pub-id></mixed-citation></ref><ref id="cytoa24230-bib-0045"><label>45</label><mixed-citation publication-type="journal" id="cytoa24230-cit-0045"><string-name name-style="western"><surname>Pahl</surname><given-names>JHW</given-names></string-name>, <string-name name-style="western"><surname>Koch</surname><given-names>J</given-names></string-name>, <string-name name-style="western"><surname>Gotz</surname><given-names>JJ</given-names></string-name>, <string-name name-style="western"><surname>Arnold</surname><given-names>A</given-names></string-name>, <string-name name-style="western"><surname>Reusch</surname><given-names>U</given-names></string-name>, <string-name name-style="western"><surname>Gantke</surname><given-names>T</given-names></string-name>, <string-name name-style="western"><surname>Rajkovic</surname><given-names>E</given-names></string-name>, <string-name name-style="western"><surname>Treder</surname><given-names>M</given-names></string-name>, <string-name name-style="western"><surname>Cerwenka</surname><given-names>A</given-names></string-name>. <article-title>CD16A activation of NK cells promotes NK cell proliferation and memory&#8208;like cytotoxicity against cancer cells</article-title>. <source xml:lang="en">Cancer Immunol Res</source><year>2018</year>;<volume>6</volume>:<fpage>517</fpage>&#8211;<lpage>527</lpage>.<pub-id pub-id-type="pmid">29514797</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1158/2326-6066.CIR-17-0550</pub-id></mixed-citation></ref><ref id="cytoa24230-bib-0046"><label>46</label><mixed-citation publication-type="journal" id="cytoa24230-cit-0046"><string-name name-style="western"><surname>Le Gars</surname><given-names>M</given-names></string-name>, <string-name name-style="western"><surname>Seiler</surname><given-names>C</given-names></string-name>, <string-name name-style="western"><surname>Kay</surname><given-names>AW</given-names></string-name>, <string-name name-style="western"><surname>Bayless</surname><given-names>NL</given-names></string-name>, <string-name name-style="western"><surname>Sola</surname><given-names>E</given-names></string-name>, <string-name name-style="western"><surname>Starosvetsky</surname><given-names>E</given-names></string-name>, <string-name name-style="western"><surname>Moore</surname><given-names>L</given-names></string-name>, <string-name name-style="western"><surname>Shen&#8208;Orr</surname><given-names>SS</given-names></string-name>, <string-name name-style="western"><surname>Aziz</surname><given-names>N</given-names></string-name>, <string-name name-style="western"><surname>Khatri</surname><given-names>P</given-names></string-name>, et al. <article-title>CD38 contributes to human natural killer cell responses through a role in immune synapse formation</article-title>. <source xml:lang="en">bioRxiv</source><year>2019</year><pub-id pub-id-type="doi">10.1101/349084</pub-id>.</mixed-citation></ref><ref id="cytoa24230-bib-0047"><label>47</label><mixed-citation publication-type="journal" id="cytoa24230-cit-0047"><string-name name-style="western"><surname>Eller</surname><given-names>MA</given-names></string-name>, <string-name name-style="western"><surname>Currier</surname><given-names>JR</given-names></string-name>. <article-title>OMIP&#8208;007: Phenotypic analysis of human natural killer cells</article-title>. <source xml:lang="en">Cytom Part A</source><year>2012</year>;<volume>81A</volume>:<fpage>447</fpage>&#8211;<lpage>449</lpage>.<pub-id pub-id-type="doi" assigning-authority="pmc">10.1002/cyto.a.22033</pub-id><pub-id pub-id-type="pmid">22411905</pub-id></mixed-citation></ref><ref id="cytoa24230-bib-0048"><label>48</label><mixed-citation publication-type="journal" id="cytoa24230-cit-0048"><string-name name-style="western"><surname>Mahnke</surname><given-names>YD</given-names></string-name>, <string-name name-style="western"><surname>Beddall</surname><given-names>MH</given-names></string-name>, <string-name name-style="western"><surname>Roederer</surname><given-names>M</given-names></string-name>. <article-title>OMIP&#8208;029: Human NK&#8208;cell phenotypization</article-title>. <source xml:lang="en">Cytom Part A</source><year>2015</year>;<volume>87A</volume>:<fpage>986</fpage>&#8211;<lpage>988</lpage>.<pub-id pub-id-type="doi" assigning-authority="pmc">10.1002/cyto.a.22728</pub-id><pub-id pub-id-type="pmid">26228006</pub-id></mixed-citation></ref><ref id="cytoa24230-bib-0049"><label>49</label><mixed-citation publication-type="journal" id="cytoa24230-cit-0049"><string-name name-style="western"><surname>Dintwe</surname><given-names>O</given-names></string-name>, <string-name name-style="western"><surname>Rohith</surname><given-names>S</given-names></string-name>, <string-name name-style="western"><surname>Schwedhelm</surname><given-names>KV</given-names></string-name>, <string-name name-style="western"><surname>McElrath</surname><given-names>MJ</given-names></string-name>, <string-name name-style="western"><surname>Andersen&#8208;Nissen</surname><given-names>E</given-names></string-name>, <string-name name-style="western"><surname>De Rosa</surname><given-names>SC</given-names></string-name>. <article-title>OMIP&#8208;056: Evaluation of human conventional T cells, donor&#8208;unrestricted T cells, and NK cells including memory phenotype by intracellular cytokine staining</article-title>. <source xml:lang="en">Cytom Part A</source><year>2019</year>;<volume>95A</volume>:<fpage>722</fpage>&#8211;<lpage>725</lpage>.<pub-id pub-id-type="doi" assigning-authority="pmc">10.1002/cyto.a.23753</pub-id><pub-id pub-id-type="pmcid">PMC6663658</pub-id><pub-id pub-id-type="pmid">30919583</pub-id></mixed-citation></ref><ref id="cytoa24230-bib-0050"><label>50</label><mixed-citation publication-type="journal" id="cytoa24230-cit-0050"><string-name name-style="western"><surname>Liechti</surname><given-names>T</given-names></string-name>, <string-name name-style="western"><surname>Roederer</surname><given-names>M</given-names></string-name>. <article-title>OMIP&#8208;058: 30&#8208;parameter flow cytometry panel to characterize iNKT, NK, unconventional and conventional T cells</article-title>. <source xml:lang="en">Cytom Part A</source><year>2019</year>;<volume>95A</volume>:<fpage>946</fpage>&#8211;<lpage>951</lpage>.<pub-id pub-id-type="doi" assigning-authority="pmc">10.1002/cyto.a.23850</pub-id><pub-id pub-id-type="pmid">31334918</pub-id></mixed-citation></ref><ref id="cytoa24230-bib-0051"><label>51</label><mixed-citation publication-type="journal" id="cytoa24230-cit-0051"><string-name name-style="western"><surname>Hertoghs</surname><given-names>N</given-names></string-name>, <string-name name-style="western"><surname>Schwedhelm</surname><given-names>KV</given-names></string-name>, <string-name name-style="western"><surname>Stuart</surname><given-names>KD</given-names></string-name>, <string-name name-style="western"><surname>McElrath</surname><given-names>MJ</given-names></string-name>, <string-name name-style="western"><surname>De Rosa</surname><given-names>SC</given-names></string-name>. <article-title>OMIP&#8208;064: A 27&#8208;color flow Cytometry panel to detect and characterize human NK cells and other innate lymphoid cell subsets, MAIT cells, and gammadelta T cells</article-title>. <source xml:lang="en">Cytom Part A</source><year>2020</year><pub-id pub-id-type="doi">10.1002/cyto.a.24031</pub-id><pub-id pub-id-type="pmcid">PMC8485754</pub-id><pub-id pub-id-type="pmid">32415811</pub-id></mixed-citation></ref><ref id="cytoa24230-bib-0052"><label>52</label><mixed-citation publication-type="journal" id="cytoa24230-cit-0052"><string-name name-style="western"><surname>Costanzo</surname><given-names>MC</given-names></string-name>, <string-name name-style="western"><surname>Creegan</surname><given-names>M</given-names></string-name>, <string-name name-style="western"><surname>Lal</surname><given-names>KG</given-names></string-name>, <string-name name-style="western"><surname>Eller</surname><given-names>MA</given-names></string-name>. <article-title>OMIP&#8208;027: Functional analysis of human natural killer cells</article-title>. <source xml:lang="en">Cytom Part A</source><year>2015</year>;<volume>87</volume>:<fpage>803</fpage>&#8211;<lpage>805</lpage>.<pub-id pub-id-type="doi" assigning-authority="pmc">10.1002/cyto.a.22719</pub-id><pub-id pub-id-type="pmid">26189970</pub-id></mixed-citation></ref><ref id="cytoa24230-bib-0053"><label>53</label><mixed-citation publication-type="journal" id="cytoa24230-cit-0053"><string-name name-style="western"><surname>Hammer</surname><given-names>Q</given-names></string-name>, <string-name name-style="western"><surname>Romagnani</surname><given-names>C</given-names></string-name>. <article-title>OMIP&#8208;039: Detection and analysis of human adaptive NKG2C(+) natural killer cells</article-title>. <source xml:lang="en">Cytom Part A</source><year>2017</year>;<volume>91</volume>:<fpage>997</fpage>&#8211;<lpage>1000</lpage>.<pub-id pub-id-type="doi" assigning-authority="pmc">10.1002/cyto.a.23168</pub-id><pub-id pub-id-type="pmid">28715616</pub-id></mixed-citation></ref></ref-list></back></article></pmc-articleset>